SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
nmo12217-sup-0001-FigS1.tiffTIFF image163KFigure S1. PAC-SYM effect sizes at week 12 in women in whom laxatives had failed to provide adequate relief – integrated analysis of three identical double-blind phase III trials – excluding women without presence of a symptom at baseline. BM, bowel movement; PAC-SYM, Patient Assessment of Constipation Symptoms; PRU, prucalopride. Effect sizes were derived excluding patients without the presence of a particular symptom at baseline (i.e., PAC-SYM score 0 and no improvement possible).
nmo12217-sup-0002-TableS1-S2.docxWord document19K

Table S1. PAC-SYM effect sizes in women in whom laxatives had failed to provide adequate relief – integrated analysis of three identical double-blind phase III trials – including women without presence of a symptom at baseline.

Table S2. PAC-SYM effect sizes in women in whom laxatives had failed to provide adequate relief – integrated analysis of three identical double-blind phase III trials – excluding women without presence of a symptom at baseline.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.